Info: Zenodo’s user support line is staffed on regular business days between Dec 23 and Jan 5. Response times may be slightly longer than normal.

Published July 29, 2022 | Version v1
Journal article Open

WOMEN'S HAIR LOSS: PATHOPHYSIOLOGICAL, DIAGNOSTIC AND THERAPEUTIC ASPECTS

Creators

  • 1. Shupic National Healthcare University of Ukraine, Kyiv, Ukraine
  • 2. Kharkiv Medical Academy of Postgraduate Education, Kharkiv, Ukraine

Description

The article presents a review of modern ukrainian and foreign publications on the pathogenesis, clinical manifestations and diagnostics of female pattern hair loss (FPHL), which is a common type of hair loss and its frequency increases with age. The questions of terminology, disease prevalence, and risk factors of hair loss are considered. It is emphasized that FPHL is a clinical problem and that it is advisable to clarify the comorbid profile of female patients and to screen for metabolic disorders.
There is still no complete understanding of the pathophysiology of FPHL. There is evidence that hormonal, genetic, and environmental factors are involved in the process of hair loss in women. Current data concerning systemic hormonal disturbances in ovarian and adrenal gland diseases in women as well as the importance of disorders of androgen-dependent mechanisms of regulation of the hair follicle growth cycle are presented.The attention is drawn to genetic abnormalities in the case of FPHL. The role of growth factors, cytokines, microinflammation, iron deficiency, perifollicular fibrosis, oxidative stress in regression of the hair follicle is considered.
FPHL is characterized as non-scarring alopecia, which develops due to progressive miniaturization of hair follicles and further hair reduction, especially in the central (frontal and parietal) scalp, gradual replacement of long terminal hair by short pubic (vellus) hair. Three models of female hair loss, modern classification according to the stages of progression used in practice, possible causes of clinical differences in alopecia in men and women are presented.
The main directions of diagnostics (history, clinical and laboratory examination, special dermatological tests) are outlined, the possibilities of modern noninvasive diagnostic method of dermoscopy are emphasized. Pharmacotherapy, recommended on the basis of evidence-based medicine, is limited to two drugs – topical minoxidil and systemic finasteride. The necessity of interdisciplinary approach to the management of patients with FPHL has been proved.

Files

Women’s hair loss_pathophysiological, diagnostic and therapeutic aspects.pdf

Files (508.9 kB)

Additional details

References

  • Kaliuzhna LD, Hrechanska LV, Petrenko AV. System support in the forming and growth of hair in alopecias and the disorders of hair shaft. Dermatol Venereol Ukraine. 2020;2(80):29-34.
  • Lin RL, Garibyan L, Kimball AB, Drake LA. Systemic causes of hair loss. Ann Med. 2016;48(6):393-402. doi: 10.1080/07853890.2016.1180426.
  • Mubki T, Rudnicka L, Olszewska M, Shapiro J. Evaluation and diagnosis of the hair loss patient. Part I. History and clinical examination. J Am Acad Dermatol. 2014;71(3):415.e1-415.e15. doi: 10.1016/j.jaad.2014.04.070.
  • Sinclair RD. Androgenetic alopecia and pattern hair loss. In: Griffiths C, Berker J, Bleiher T, Chalmes R, Creamer D, editors. Rook's Textbook of Dermatology, 9th ed. Vol. 3, part 8 (8.9). London: Willey; 2016.
  • Davis DS, Callender VD. Review of quality of life studies in women with alopecia. Int J Womens Dermatol. 2018;4(1):18-22. doi: 10.1016/j.ijwd.2017.11.007.
  • Park J, Kim JI, Yun SK, Kim HU, Ihm CW. Pattern alopecia during hormonal anticancer therapy in patients with breast cancer. Ann Dermatol. 2014;26(6):743-6. doi: 10.5021/ad.2014.26.6.743.
  • Bolognia J, Schaffer J, Cerroni L, editors. Dermatol. 4th ed. Philadelphia, PA: Elsevier; 2017. 1145-61 p.
  • Trüeb RM, Rezende HD, Fernanda M, Dias GA. Comment on the science of hair aging. Int J Mol Sci. 2020;21:5342. doi: 10.3390/ijms21155342.
  • Desai K, Almeida B, Miteva M. Understanding hormonal therapies: overview for the dermatologist focused on hair. Dermatol. 2021;237:786-91. doi: 10.1159/000512888.
  • Sidorova IV, Tutchenko TM, Burka OA, Semeniuk LM, Nohovska IG, Demianenko LV. Androgen-associated and androgen-independent causes of alopecia and acne in women. Reprod Endocrinol. Ukraine. 2020;52(2):39-48. https://doi.org/10. 18370/2309-4117.2020.52.39-48.
  • Redler S, Messenger AG, Betz RC. Genetics and other factors in the aetiology of female pattern hair loss. Experimental Dermatol. 2017;26(6):510-7. doi: 10.1111/ exd.13373.
  • Diba S, Gozali MM, Kurniawati Y. Diagnosis and management of female pattern hair loss. J Biosci Med. 2019;4(1):29-47. doi: 10.32539/bsm.v4i1.111.
  • Ramos PM, Miot HA. Female pattern hair loss: a clinical and pathophysiological review. Ann Bras Dermatol. 2015;90(4):529-43. doi: 10.1590/abd1806-4841.20153370.
  • Harries M, Tosti A, Bergfeld W, Peytavi UB, Shapiro J, Lutz G, et al. Towards consensus on how to diagnose and quantify female pattern hair loss – The 'Female Pattern Hair Loss Severity Index (FPHL-SI)'. J Eur Acad Dermatol Venereol. 2016;30(4):667-76. doi: 10.1111/jdv.13455.
  • Tamashunas NL, Bergfeld WF. Male and female pattern hair loss: Treatable and worth treating. Cleve Clin J Med. 2021;88(3):173-82. doi: 10.3949/ccjm.88a.20014.
  • Sanchez P, Serrano-Falcon C, Torres JM, Serrano S, Ortega E. 5a-reductase isozymes and aromatase mRNA levels in plucked hair from young women with female pattern hair loss. Archives Dermatol Res. 2018;310(1):77e83. doi: 10.1007/s00403-017-1798-0.
  • Lin X, Zhu L, He J. Morphogenesis, growth cycle and molecular regulation of hair follicles. Front Cell Dev Biol. 2022;10:Article 899095. doi: 10.3389/fcell.2022.899095.
  • Premanand A, Rajkumari RB. Androgen modulation of Wnt/β-catenin signaling in androgenetic alopecia. Arch Dermatol Res. 2018;310(5):391. doi: 10.1007/s00403-018-1826-8.
  • Grymowicz M, Rudnicka E, Podfigurna A, Napierala P, Smolarczyk R, Smolarczyk K, Meczekalski B. Hormonal effects on hair follicles. Int J Mol Sci. 2020;21(15):5342. doi: 10.3390/ijms21155342.
  • Blume-Peytavi U, Blumeyer A, Tosti A, Finner A, Marmol V, Trakatelli M, et al. S1 guideline for diagnostic evaluation in androgenetic alopecia in men, women and adolescents. British J Dermatol. 2011;164:5-15. doi: 10.1111/j.1365-2133.2010.10011.x.
  • Vujovic A, Del Marmol V. The female pattern hair loss: Review of etiopathogenesis and diagnosis. BioMed Res Int. 2014;2014:8. doi: 10.1155/2014/767628.
  • Trüeb RM. Understanding pattern hair loss - hair biology impacted by genes, androgens, prostaglandins and epigenetic factors. Indian J Plast Surg. 2021;54(4):385-92. doi: 10.1055/s-0041-1739252.
  • Williams R, Westgate RG, Pawlus AD, Sikkink SK, Thornton MJ. Age-related changes in female scalp dermal sheath and dermal fibroblasts: How the hair follicle environment impacts hair aging. J Invest Dermatol. 2021;141(4S):1041-51. doi: 10.1016/j.jid.2020.11.009.
  • Su LH, Chen LS, Chen HH. Factors associated with female pattern hair loss and its prevalence in Taiwaese women: a community-based survey. J Am Acad Dermatol. 2013;69(2):556-77. doi: 10.1016/j.jaad.2012.09.046.
  • Sheikh FZ, Butt G, Hafeez R, Maqsood A, Altaf F, Hussain I. Association of early-onset androgenetic alopecia and metabolic syndrome. J Coll Physicians Surg Pak. 2021;31(2):123-7. doi: 10.29271/jcpsp.2021.02.123.
  • Qiu Y, Zhou X, Fu S, Luo S, Li Y. Systematic Review and Meta-analysis of the Association between metabolic syndrome and androgenetic alopecia. Acta Derm Venereol. 2022;102:adv00645. doi: 10.2340/actadv.v101.1012.
  • Nguyen B, Tosti A. Alopecia in patients with COVID-19: A systematic review and meta-analysis. J Am Acad Dermatol. 2022;7:67-77. doi: 10.1016/j.jdin.2022.02.006.
  • Montopoli M, Zumerle S, Vettor R, Rugge M, Zorzi M, Catapano CV, et al. Androgen-deprivation therapies for prostate cancer and risk of infection by SARSCoV-2: a population-based study (N = 4532). Ann Oncol. 2020;31(8):1040-5. doi: 10.1016/j.annonc.2020.04.479.
  • Van Zuuren EJ, Fedorowicz Z, Schoones J. Interventions for female pattern hair loss. Cochrane Database Syst Rev. 2016;2016(5):CD007628. doi: 10.1002/14651858.CD007628.pub4.
  • Dlova NC, Fabbrocini G, Lauro C, Spano M, Tosti A, Hift RH. Quality of life in South African Black women with alopecia: a pilot study. Int J Dermatol. 2016;55(8):875-81. doi: 10.1111/ijd.13042.
  • Ceruti JM, Leiros GJ, Balana ME. Androgens and androgen receptor action in skin and hair follicles. Mol Cell Endocrinolol. 2018;465:122-33. doi: 10.1016/j.mce.2017.09.009.
  • Miranda BH, Charlesworth MR, Tobin DJ, Sharpe DT, Randall VA. Androgens trigger different growth responses in genetically identical human hair follicles in organ culture that reflect their epigenetic diversity in life. FASEB J. 2018;32(2):795-806. doi: 10.1096/fj.201700260RR.
  • Chu TW, Santos L, McElwee KJ. Biology of the hair follicle and mechanisms of nonscarring and scarring alopecia. Semin Cutan Med Surg. 2015;34(2):50-6. doi: 10.12788/j.sder.2015.0133.
  • Ashraf S, Nabi М, Rasool SA, Rashid F, Amin S. Hyperandrogenism in polycystic ovarian syndrome and role of CYP gene variants: a review. Egypt J Med Hum Genet. 2019;20:25. doi: 10.1186/s43042-019-0031-4.
  • Quinn M, Shinkai K, Pasch L, Kuzmich L, Cedars M, Huddleston H. Prevalence of androgenic alopecia in patients with polycystic ovary syndrome and characterization of associated clinical and biochemical features. Fertility and Sterility. 2014;101(4):1129-34. doi: 10.1016/j.fertnstert.2014.01.003.
  • Carmina E, Azziz R, Bergfeld W, Escobar-Morreale HF, Futterweit W, Huddleston H, et al. Female pattern hair loss and androgen excess: A report from the multidisciplinary androgen excess and PCOS Committee. J Clin Endocrinol Metab. 2019;104(7):2875-91. doi: 10.1210/jc.2018-02548.
  • Herskovitz I, Tosti A. Female pattern hair loss. Int J Endocrinol Metab. 2013;11(4):e9860. doi: 10.5812/ijem.9860.
  • Endo Y, Takahashi M, Obayashi Y, Serizawa T, Murakoshi M, Ohyama M. The ovariectomized mouse simulates the pathophysiology of postmenopausal female pattern hair loss. J Dermatol Sci. 2017;87(1):79-82. doi: 10.1016/j.jdermsci.2017.04.002.
  • Freites-Martinez A, Shapiro J, Chan D, Fornier M, Modi S, Gajria D, et al. Endocrine therapy-induced alopecia in patients with breast cancer. JAMA Dermatol. 2018;154(6):670-5.
  • Heilmann-Heimbach S, Herold C, Hochfeld LM, Hillmer AM, Nyholt DR, Hecker J, et al. Meta-analysis identifies novel risk loci and yields systematic insights into the biology of male-pattern baldness. Nat Commun. 2017;8:14694. doi: 10.1038/ncomms14694.
  • Pickrell JK, Berisa T, Liu JZ, Segureal L, Tung JY, Hinds DA. Detection and interpretation of shared genetic influences on 42 human traits. Nat Genet. 2016;48:709-17. doi: 10.1038/ng.3570.
  • Ramos PM, Brianezi G, Martins AC, Da Silva MG, Marques ME, Miot HA. Apoptosis in follicles of individuals with female pattern hair loss is associated with perifollicular microinflammation. Int J Cosmetic Sci. 2016;38(6):651-4. doi: 10.1111/ ics.12341.
  • Park SY, Na SY, Kim JH, Cho S, Lee JH. Iron plays a certain role in patterned hair loss. J Korean Med Sci. 2013;28(6):934-8. doi: 10.3346/jkms.2013.28.6.934.
  • Torkamani N, Rufaut NW, Jones L, Sinclair R. Destruction of the arrector pili muscle and fat infiltration in androgenic alopecia. Br J Dermatol. 2014;170(6):1291-8.
  • Merlotto MR, Ramod PM. Pattern hair loss: assessment of microinflammation in miniaturized and terminal hair follicles through horizontal histologic sections. J Am Acad Dermatol. 2020;83(2):e145-e146. doi: 10.1016/j.jaad.2020.03.119.
  • Kanti V, Messenger A, Dobos G, Reygagne P, Finner A, Blumeyer A, et al. Evidence based (S3) guidelines for the treatment of androgenetic alopecia in women and in men – short version. J Eur Acad Dermatol Venereol. 2018;32(1):11-22. doi: 10.1111/jdv.14624.
  • Adil A, Godwin M. The effectiveness of treatments for androgenetic alopecia: A systematic review and meta-analysis. J Ame Acad Dermatol. 2017;77(1):136-141.e5. doi: 10.1016/j.jaad.2017.02.054.